Efficacy evaluation

               - characterization of antioxidative properties (ORAC assay)                            
               - characterization of anti-hypertensive properties (ACE inhibition)                
               - regulation of bone density (in vitro and in vivo)
               - regulation of lipidic metabolism (in vitro and in vivo)

       Safety and allergy studies

                          - In vitro
Mutageneis studies (AMES) assay
                          - Genotoxicity studies (Micro-nucleus assay, CHO-K1 cell line)

                          - In vivo
Acute and chronic toxicity  studies
                          - Allergy studies (mice)
Moreover, C.RIS Pharma can also develop specific tests or cell models in adequacy with your needs.
 photo credit: D..Auvray - C.RIS Pharma - All rights reserved - copy prohibited